General Info

ZIOPHARM Oncology is a biopharmaceutical company that focuses on the development and commercialization of a variety of cancer curing drugs. It conducts research and development studies, as well as performs clinical trials. The company has discovered Zymafos, a molecule that is the functional active metabolite of ifosfamide that is utilized in treating sarcoma and testicular cancer. It is also conducting various phases of clinical trials for Zinapar, which is an organic arsenic developed for the treatment of various types of hematological and solid cancers. ZIOPHARM Oncology additionally utilizes various biomarkers, as well as computer modeling and simulation technologies for performing clinical trial processes.